Palifermin has 3 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Myelotoxic Chemotherapy, Heparin, Low Molecular Weight Heparin. Patients taking Palifermin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 1
- Moderate
- 2
Major (1)
- Palifermin + Myelotoxic Chemotherapy— Do not administer palifermin within 24 hours before, during, or within 24 hours after myelotoxic chemotherapy. Administr…
Moderate (2)
- Palifermin + Heparin— Palifermin interacts with unfractionated heparin; heparin increases systemic exposure of palifermin. Rinse IV line with …
- Palifermin + Low Molecular Weight Heparin— Palifermin interacts with low molecular weight heparins; heparin increases systemic exposure of palifermin. Rinse IV lin…